These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Role of vascular nitric oxide in physiological and pathological conditions. Marín J; Rodríguez-Martínez MA Pharmacol Ther; 1997 Aug; 75(2):111-34. PubMed ID: 9428001 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and its role in the cardiovascular system. Loscalzo J; Welch G Prog Cardiovasc Dis; 1995; 38(2):87-104. PubMed ID: 7568906 [TBL] [Abstract][Full Text] [Related]
7. [Nitric oxide--a basic mediator of vasodilation and septic shock]. Vasilev D; Karadimov D; Vogt J; Santak B Khirurgiia (Sofiia); 1996; 49(4):14-6. PubMed ID: 8968135 [TBL] [Abstract][Full Text] [Related]
8. Nitric oxide in the pathogenesis of vascular disease. Li H; Förstermann U J Pathol; 2000 Feb; 190(3):244-54. PubMed ID: 10685059 [TBL] [Abstract][Full Text] [Related]
13. The tragedy of TRIUMPH for nitric oxide synthesis inhibition in cardiogenic shock: where do we go from here? Bailey A; Pope TW; Moore SA; Campbell CL Am J Cardiovasc Drugs; 2007; 7(5):337-45. PubMed ID: 17953472 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta. Joly GA; Narayanan K; Griffith OW; Kilbourn RG Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462 [TBL] [Abstract][Full Text] [Related]
15. Nitric oxide. A key mediator in sepsis and endotoxaemia? Parratt JR J Physiol Pharmacol; 1997 Dec; 48(4):493-506. PubMed ID: 9444603 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial nitric oxide synthase participates in septic shock myocardial depression by nitric oxide overproduction and mitochondrial permeability transition pore opening. Xu C; Yi C; Wang H; Bruce IC; Xia Q Shock; 2012 Jan; 37(1):110-5. PubMed ID: 21993446 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953 [TBL] [Abstract][Full Text] [Related]